Moreover, EOS have improved chemotaxis to eotaxins in the presence of IL-4 (49), suggesting that the combination of reduced IL-4 and reduced eotaxin/CCR3 expression during obesity could compound the ability of EOS to migrate into AT. The gene discussed is IL4; the disease is obesity disorder.